Use of Immunomodulators (Thymopentine) in Hepatitis B Vaccine in Elderly Patients Undergoing Chronic Hemodialysis | Citedby Results | Nephron | Karger Publishers

Skip to Main Content

Skip Nav Destination

Use of Immunomodulators (Thymopentine) in Hepatitis B Vaccine in Elderly Patients Undergoing Chronic Hemodialysis

Nephron (1992) 61 (3): 358–359.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients

Alba Vilajeliu
Víctor-Guillermo Sequera
Alberto L. García-Basteiro
Elisa Sicuri
Marta Aldea
César Velasco
José M. Bayas

Human Vaccines & Immunotherapeutics (2016) 12 (9): 2317.

Meta‐analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end‐stage renal disease

F. FABRIZI
V. DIXIT
P. MARTIN

Alimentary Pharmacology & Therapeutics (2006) 23 (11): 1559.

LIVER DISEASE IN THE ELDERLY

Arie Regev
Eugene R. Schiff

Gastroenterology Clinics of North America (2001) 30 (2): 547.

Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis

Yujin Hoshida
Kenji Ikeda
Masahiro Kobayashi
Yoshiyuki Suzuki
Akihito Tsubota
Satoshi Saitoh
Yasuji Arase
Mizuho Kobayashi
Naoya Murashima
Kazuaki Chayama
Hiromitsu Kumada

Journal of Hepatology (1999) 31 (5): 860.

Enzymatic Cleavage of Thymopoietin Oligopeptides by Pancreatic and Intestinal Brush-Border Enzymes

J. HEIZMANN
P. LANGGUTH
A. BIBER
R. OSCHMANN
H.P. MERKLE
S. WOLFFRAM

Peptides (1996) 17 (7): 1083.

Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production

Jane N. Zuckerman

Journal of Medical Virology (1996) 50 (4): 283.